ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global AI In Vitro Diagnostic Market Research Report 2025
Published Date: May 2025
|
Report Code: QYRE-Auto-21Z14658
Home | Market Reports | Health
Global AI In Vitro Diagnostic Market Research Report 2023
BUY CHAPTERS

Global AI In Vitro Diagnostic Market Research Report 2025

Code: QYRE-Auto-21Z14658
Report
May 2025
Pages:97
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Seegene
Sysmex
PathAI
Prognos
Qiagen NV
CloudMedX Health
Digital Diagnostics
EKF Diagnostics Holdings
Freenome
GE Healthcare
Glooko
Adaptive Biotechnologies
Aidoc
ARUP Laboratories
K Health
Lunit
Renalytix
Deepcell
Anumana

AI In Vitro Diagnostic Market

The global market for AI In Vitro Diagnostic was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
The global market for in vitro diagnostics (IVD) was growing steadily and was expected to continue its growth in the coming years.
Market Overview: The in vitro diagnostics market involves medical devices, instruments, and reagents used for diagnostic testing of samples such as blood, urine, tissue, and other bodily fluids. AI in vitro diagnostics refers to the integration of artificial intelligence and machine learning technologies into these diagnostic tools and processes.
Growth Drivers: The market for AI in vitro diagnostics has been driven by factors such as increasing demand for personalized medicine, rising prevalence of chronic and infectious diseases, technological advancements in diagnostics, and the need for efficient and accurate diagnostic solutions.
Application Areas: AI has found applications in various areas of in vitro diagnostics, including clinical chemistry, immunoassays, microbiology, hematology, genetic testing, and molecular diagnostics. AI algorithms can aid in data analysis, interpretation, and decision-making, improving the accuracy and efficiency of diagnostic procedures.
This report aims to provide a comprehensive presentation of the global market for AI In Vitro Diagnostic, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding AI In Vitro Diagnostic.
The AI In Vitro Diagnostic market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global AI In Vitro Diagnostic market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the AI In Vitro Diagnostic companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of AI In Vitro Diagnostic Market Report

Report Metric Details
Report Name AI In Vitro Diagnostic Market
Segment by Type
  • Next-Generation Sequencing Technology
  • PCR Technology
  • Chemistry and IA Technology
  • Pathology Technology
Segment by Application
  • Cancer Diagnostics
  • Infectious Disease Testing
  • Metabolic Testing
  • Cardiac Testing
  • Diabetes Testing
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Renalytix, Seegene, Sysmex, PathAI, Prognos, Qiagen, CloudMedX Health, Deepcell, Digital Diagnostics, EKF Diagnostics Holdings, Freenome, GE Healthcare, Glooko, Adaptive Biotechnologies, Aidoc, Anumana, ARUP Laboratories, K Health, Lunit
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of AI In Vitro Diagnostic company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the AI In Vitro Diagnostic Market report?

Ans: The main players in the AI In Vitro Diagnostic Market are Renalytix, Seegene, Sysmex, PathAI, Prognos, Qiagen, CloudMedX Health, Deepcell, Digital Diagnostics, EKF Diagnostics Holdings, Freenome, GE Healthcare, Glooko, Adaptive Biotechnologies, Aidoc, Anumana, ARUP Laboratories, K Health, Lunit

What are the Application segmentation covered in the AI In Vitro Diagnostic Market report?

Ans: The Applications covered in the AI In Vitro Diagnostic Market report are Cancer Diagnostics, Infectious Disease Testing, Metabolic Testing, Cardiac Testing, Diabetes Testing

What are the Type segmentation covered in the AI In Vitro Diagnostic Market report?

Ans: The Types covered in the AI In Vitro Diagnostic Market report are Next-Generation Sequencing Technology, PCR Technology, Chemistry and IA Technology, Pathology Technology

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global AI In Vitro Diagnostic Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Next-Generation Sequencing Technology
1.2.3 PCR Technology
1.2.4 Chemistry and IA Technology
1.2.5 Pathology Technology
1.3 Market by Application
1.3.1 Global AI In Vitro Diagnostic Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Cancer Diagnostics
1.3.3 Infectious Disease Testing
1.3.4 Metabolic Testing
1.3.5 Cardiac Testing
1.3.6 Diabetes Testing
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global AI In Vitro Diagnostic Market Perspective (2020-2031)
2.2 Global AI In Vitro Diagnostic Growth Trends by Region
2.2.1 Global AI In Vitro Diagnostic Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 AI In Vitro Diagnostic Historic Market Size by Region (2020-2025)
2.2.3 AI In Vitro Diagnostic Forecasted Market Size by Region (2026-2031)
2.3 AI In Vitro Diagnostic Market Dynamics
2.3.1 AI In Vitro Diagnostic Industry Trends
2.3.2 AI In Vitro Diagnostic Market Drivers
2.3.3 AI In Vitro Diagnostic Market Challenges
2.3.4 AI In Vitro Diagnostic Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top AI In Vitro Diagnostic Players by Revenue
3.1.1 Global Top AI In Vitro Diagnostic Players by Revenue (2020-2025)
3.1.2 Global AI In Vitro Diagnostic Revenue Market Share by Players (2020-2025)
3.2 Global AI In Vitro Diagnostic Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by AI In Vitro Diagnostic Revenue
3.4 Global AI In Vitro Diagnostic Market Concentration Ratio
3.4.1 Global AI In Vitro Diagnostic Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by AI In Vitro Diagnostic Revenue in 2024
3.5 Global Key Players of AI In Vitro Diagnostic Head office and Area Served
3.6 Global Key Players of AI In Vitro Diagnostic, Product and Application
3.7 Global Key Players of AI In Vitro Diagnostic, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 AI In Vitro Diagnostic Breakdown Data by Type
4.1 Global AI In Vitro Diagnostic Historic Market Size by Type (2020-2025)
4.2 Global AI In Vitro Diagnostic Forecasted Market Size by Type (2026-2031)
5 AI In Vitro Diagnostic Breakdown Data by Application
5.1 Global AI In Vitro Diagnostic Historic Market Size by Application (2020-2025)
5.2 Global AI In Vitro Diagnostic Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America AI In Vitro Diagnostic Market Size (2020-2031)
6.2 North America AI In Vitro Diagnostic Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America AI In Vitro Diagnostic Market Size by Country (2020-2025)
6.4 North America AI In Vitro Diagnostic Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe AI In Vitro Diagnostic Market Size (2020-2031)
7.2 Europe AI In Vitro Diagnostic Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe AI In Vitro Diagnostic Market Size by Country (2020-2025)
7.4 Europe AI In Vitro Diagnostic Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific AI In Vitro Diagnostic Market Size (2020-2031)
8.2 Asia-Pacific AI In Vitro Diagnostic Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific AI In Vitro Diagnostic Market Size by Region (2020-2025)
8.4 Asia-Pacific AI In Vitro Diagnostic Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America AI In Vitro Diagnostic Market Size (2020-2031)
9.2 Latin America AI In Vitro Diagnostic Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America AI In Vitro Diagnostic Market Size by Country (2020-2025)
9.4 Latin America AI In Vitro Diagnostic Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa AI In Vitro Diagnostic Market Size (2020-2031)
10.2 Middle East & Africa AI In Vitro Diagnostic Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa AI In Vitro Diagnostic Market Size by Country (2020-2025)
10.4 Middle East & Africa AI In Vitro Diagnostic Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Renalytix
11.1.1 Renalytix Company Details
11.1.2 Renalytix Business Overview
11.1.3 Renalytix AI In Vitro Diagnostic Introduction
11.1.4 Renalytix Revenue in AI In Vitro Diagnostic Business (2020-2025)
11.1.5 Renalytix Recent Development
11.2 Seegene
11.2.1 Seegene Company Details
11.2.2 Seegene Business Overview
11.2.3 Seegene AI In Vitro Diagnostic Introduction
11.2.4 Seegene Revenue in AI In Vitro Diagnostic Business (2020-2025)
11.2.5 Seegene Recent Development
11.3 Sysmex
11.3.1 Sysmex Company Details
11.3.2 Sysmex Business Overview
11.3.3 Sysmex AI In Vitro Diagnostic Introduction
11.3.4 Sysmex Revenue in AI In Vitro Diagnostic Business (2020-2025)
11.3.5 Sysmex Recent Development
11.4 PathAI
11.4.1 PathAI Company Details
11.4.2 PathAI Business Overview
11.4.3 PathAI AI In Vitro Diagnostic Introduction
11.4.4 PathAI Revenue in AI In Vitro Diagnostic Business (2020-2025)
11.4.5 PathAI Recent Development
11.5 Prognos
11.5.1 Prognos Company Details
11.5.2 Prognos Business Overview
11.5.3 Prognos AI In Vitro Diagnostic Introduction
11.5.4 Prognos Revenue in AI In Vitro Diagnostic Business (2020-2025)
11.5.5 Prognos Recent Development
11.6 Qiagen
11.6.1 Qiagen Company Details
11.6.2 Qiagen Business Overview
11.6.3 Qiagen AI In Vitro Diagnostic Introduction
11.6.4 Qiagen Revenue in AI In Vitro Diagnostic Business (2020-2025)
11.6.5 Qiagen Recent Development
11.7 CloudMedX Health
11.7.1 CloudMedX Health Company Details
11.7.2 CloudMedX Health Business Overview
11.7.3 CloudMedX Health AI In Vitro Diagnostic Introduction
11.7.4 CloudMedX Health Revenue in AI In Vitro Diagnostic Business (2020-2025)
11.7.5 CloudMedX Health Recent Development
11.8 Deepcell
11.8.1 Deepcell Company Details
11.8.2 Deepcell Business Overview
11.8.3 Deepcell AI In Vitro Diagnostic Introduction
11.8.4 Deepcell Revenue in AI In Vitro Diagnostic Business (2020-2025)
11.8.5 Deepcell Recent Development
11.9 Digital Diagnostics
11.9.1 Digital Diagnostics Company Details
11.9.2 Digital Diagnostics Business Overview
11.9.3 Digital Diagnostics AI In Vitro Diagnostic Introduction
11.9.4 Digital Diagnostics Revenue in AI In Vitro Diagnostic Business (2020-2025)
11.9.5 Digital Diagnostics Recent Development
11.10 EKF Diagnostics Holdings
11.10.1 EKF Diagnostics Holdings Company Details
11.10.2 EKF Diagnostics Holdings Business Overview
11.10.3 EKF Diagnostics Holdings AI In Vitro Diagnostic Introduction
11.10.4 EKF Diagnostics Holdings Revenue in AI In Vitro Diagnostic Business (2020-2025)
11.10.5 EKF Diagnostics Holdings Recent Development
11.11 Freenome
11.11.1 Freenome Company Details
11.11.2 Freenome Business Overview
11.11.3 Freenome AI In Vitro Diagnostic Introduction
11.11.4 Freenome Revenue in AI In Vitro Diagnostic Business (2020-2025)
11.11.5 Freenome Recent Development
11.12 GE Healthcare
11.12.1 GE Healthcare Company Details
11.12.2 GE Healthcare Business Overview
11.12.3 GE Healthcare AI In Vitro Diagnostic Introduction
11.12.4 GE Healthcare Revenue in AI In Vitro Diagnostic Business (2020-2025)
11.12.5 GE Healthcare Recent Development
11.13 Glooko
11.13.1 Glooko Company Details
11.13.2 Glooko Business Overview
11.13.3 Glooko AI In Vitro Diagnostic Introduction
11.13.4 Glooko Revenue in AI In Vitro Diagnostic Business (2020-2025)
11.13.5 Glooko Recent Development
11.14 Adaptive Biotechnologies
11.14.1 Adaptive Biotechnologies Company Details
11.14.2 Adaptive Biotechnologies Business Overview
11.14.3 Adaptive Biotechnologies AI In Vitro Diagnostic Introduction
11.14.4 Adaptive Biotechnologies Revenue in AI In Vitro Diagnostic Business (2020-2025)
11.14.5 Adaptive Biotechnologies Recent Development
11.15 Aidoc
11.15.1 Aidoc Company Details
11.15.2 Aidoc Business Overview
11.15.3 Aidoc AI In Vitro Diagnostic Introduction
11.15.4 Aidoc Revenue in AI In Vitro Diagnostic Business (2020-2025)
11.15.5 Aidoc Recent Development
11.16 Anumana
11.16.1 Anumana Company Details
11.16.2 Anumana Business Overview
11.16.3 Anumana AI In Vitro Diagnostic Introduction
11.16.4 Anumana Revenue in AI In Vitro Diagnostic Business (2020-2025)
11.16.5 Anumana Recent Development
11.17 ARUP Laboratories
11.17.1 ARUP Laboratories Company Details
11.17.2 ARUP Laboratories Business Overview
11.17.3 ARUP Laboratories AI In Vitro Diagnostic Introduction
11.17.4 ARUP Laboratories Revenue in AI In Vitro Diagnostic Business (2020-2025)
11.17.5 ARUP Laboratories Recent Development
11.18 K Health
11.18.1 K Health Company Details
11.18.2 K Health Business Overview
11.18.3 K Health AI In Vitro Diagnostic Introduction
11.18.4 K Health Revenue in AI In Vitro Diagnostic Business (2020-2025)
11.18.5 K Health Recent Development
11.19 Lunit
11.19.1 Lunit Company Details
11.19.2 Lunit Business Overview
11.19.3 Lunit AI In Vitro Diagnostic Introduction
11.19.4 Lunit Revenue in AI In Vitro Diagnostic Business (2020-2025)
11.19.5 Lunit Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
FEATURED COMPANIES
Seegene
Sysmex
PathAI
Prognos
Qiagen NV
CloudMedX Health
Digital Diagnostics
EKF Diagnostics Holdings
Freenome
GE Healthcare
Glooko
Adaptive Biotechnologies
Aidoc
ARUP Laboratories
K Health
Lunit
Renalytix
Deepcell
Anumana
List of Tables
 Table 1. Global AI In Vitro Diagnostic Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of Next-Generation Sequencing Technology
 Table 3. Key Players of PCR Technology
 Table 4. Key Players of Chemistry and IA Technology
 Table 5. Key Players of Pathology Technology
 Table 6. Global AI In Vitro Diagnostic Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 7. Global AI In Vitro Diagnostic Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 8. Global AI In Vitro Diagnostic Market Size by Region (2020-2025) & (US$ Million)
 Table 9. Global AI In Vitro Diagnostic Market Share by Region (2020-2025)
 Table 10. Global AI In Vitro Diagnostic Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 11. Global AI In Vitro Diagnostic Market Share by Region (2026-2031)
 Table 12. AI In Vitro Diagnostic Market Trends
 Table 13. AI In Vitro Diagnostic Market Drivers
 Table 14. AI In Vitro Diagnostic Market Challenges
 Table 15. AI In Vitro Diagnostic Market Restraints
 Table 16. Global AI In Vitro Diagnostic Revenue by Players (2020-2025) & (US$ Million)
 Table 17. Global AI In Vitro Diagnostic Market Share by Players (2020-2025)
 Table 18. Global Top AI In Vitro Diagnostic Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in AI In Vitro Diagnostic as of 2024)
 Table 19. Ranking of Global Top AI In Vitro Diagnostic Companies by Revenue (US$ Million) in 2024
 Table 20. Global 5 Largest Players Market Share by AI In Vitro Diagnostic Revenue (CR5 and HHI) & (2020-2025)
 Table 21. Global Key Players of AI In Vitro Diagnostic, Headquarters and Area Served
 Table 22. Global Key Players of AI In Vitro Diagnostic, Product and Application
 Table 23. Global Key Players of AI In Vitro Diagnostic, Date of Enter into This Industry
 Table 24. Mergers & Acquisitions, Expansion Plans
 Table 25. Global AI In Vitro Diagnostic Market Size by Type (2020-2025) & (US$ Million)
 Table 26. Global AI In Vitro Diagnostic Revenue Market Share by Type (2020-2025)
 Table 27. Global AI In Vitro Diagnostic Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 28. Global AI In Vitro Diagnostic Revenue Market Share by Type (2026-2031)
 Table 29. Global AI In Vitro Diagnostic Market Size by Application (2020-2025) & (US$ Million)
 Table 30. Global AI In Vitro Diagnostic Revenue Market Share by Application (2020-2025)
 Table 31. Global AI In Vitro Diagnostic Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 32. Global AI In Vitro Diagnostic Revenue Market Share by Application (2026-2031)
 Table 33. North America AI In Vitro Diagnostic Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 34. North America AI In Vitro Diagnostic Market Size by Country (2020-2025) & (US$ Million)
 Table 35. North America AI In Vitro Diagnostic Market Size by Country (2026-2031) & (US$ Million)
 Table 36. Europe AI In Vitro Diagnostic Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 37. Europe AI In Vitro Diagnostic Market Size by Country (2020-2025) & (US$ Million)
 Table 38. Europe AI In Vitro Diagnostic Market Size by Country (2026-2031) & (US$ Million)
 Table 39. Asia-Pacific AI In Vitro Diagnostic Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 40. Asia-Pacific AI In Vitro Diagnostic Market Size by Region (2020-2025) & (US$ Million)
 Table 41. Asia-Pacific AI In Vitro Diagnostic Market Size by Region (2026-2031) & (US$ Million)
 Table 42. Latin America AI In Vitro Diagnostic Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 43. Latin America AI In Vitro Diagnostic Market Size by Country (2020-2025) & (US$ Million)
 Table 44. Latin America AI In Vitro Diagnostic Market Size by Country (2026-2031) & (US$ Million)
 Table 45. Middle East & Africa AI In Vitro Diagnostic Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 46. Middle East & Africa AI In Vitro Diagnostic Market Size by Country (2020-2025) & (US$ Million)
 Table 47. Middle East & Africa AI In Vitro Diagnostic Market Size by Country (2026-2031) & (US$ Million)
 Table 48. Renalytix Company Details
 Table 49. Renalytix Business Overview
 Table 50. Renalytix AI In Vitro Diagnostic Product
 Table 51. Renalytix Revenue in AI In Vitro Diagnostic Business (2020-2025) & (US$ Million)
 Table 52. Renalytix Recent Development
 Table 53. Seegene Company Details
 Table 54. Seegene Business Overview
 Table 55. Seegene AI In Vitro Diagnostic Product
 Table 56. Seegene Revenue in AI In Vitro Diagnostic Business (2020-2025) & (US$ Million)
 Table 57. Seegene Recent Development
 Table 58. Sysmex Company Details
 Table 59. Sysmex Business Overview
 Table 60. Sysmex AI In Vitro Diagnostic Product
 Table 61. Sysmex Revenue in AI In Vitro Diagnostic Business (2020-2025) & (US$ Million)
 Table 62. Sysmex Recent Development
 Table 63. PathAI Company Details
 Table 64. PathAI Business Overview
 Table 65. PathAI AI In Vitro Diagnostic Product
 Table 66. PathAI Revenue in AI In Vitro Diagnostic Business (2020-2025) & (US$ Million)
 Table 67. PathAI Recent Development
 Table 68. Prognos Company Details
 Table 69. Prognos Business Overview
 Table 70. Prognos AI In Vitro Diagnostic Product
 Table 71. Prognos Revenue in AI In Vitro Diagnostic Business (2020-2025) & (US$ Million)
 Table 72. Prognos Recent Development
 Table 73. Qiagen Company Details
 Table 74. Qiagen Business Overview
 Table 75. Qiagen AI In Vitro Diagnostic Product
 Table 76. Qiagen Revenue in AI In Vitro Diagnostic Business (2020-2025) & (US$ Million)
 Table 77. Qiagen Recent Development
 Table 78. CloudMedX Health Company Details
 Table 79. CloudMedX Health Business Overview
 Table 80. CloudMedX Health AI In Vitro Diagnostic Product
 Table 81. CloudMedX Health Revenue in AI In Vitro Diagnostic Business (2020-2025) & (US$ Million)
 Table 82. CloudMedX Health Recent Development
 Table 83. Deepcell Company Details
 Table 84. Deepcell Business Overview
 Table 85. Deepcell AI In Vitro Diagnostic Product
 Table 86. Deepcell Revenue in AI In Vitro Diagnostic Business (2020-2025) & (US$ Million)
 Table 87. Deepcell Recent Development
 Table 88. Digital Diagnostics Company Details
 Table 89. Digital Diagnostics Business Overview
 Table 90. Digital Diagnostics AI In Vitro Diagnostic Product
 Table 91. Digital Diagnostics Revenue in AI In Vitro Diagnostic Business (2020-2025) & (US$ Million)
 Table 92. Digital Diagnostics Recent Development
 Table 93. EKF Diagnostics Holdings Company Details
 Table 94. EKF Diagnostics Holdings Business Overview
 Table 95. EKF Diagnostics Holdings AI In Vitro Diagnostic Product
 Table 96. EKF Diagnostics Holdings Revenue in AI In Vitro Diagnostic Business (2020-2025) & (US$ Million)
 Table 97. EKF Diagnostics Holdings Recent Development
 Table 98. Freenome Company Details
 Table 99. Freenome Business Overview
 Table 100. Freenome AI In Vitro Diagnostic Product
 Table 101. Freenome Revenue in AI In Vitro Diagnostic Business (2020-2025) & (US$ Million)
 Table 102. Freenome Recent Development
 Table 103. GE Healthcare Company Details
 Table 104. GE Healthcare Business Overview
 Table 105. GE Healthcare AI In Vitro Diagnostic Product
 Table 106. GE Healthcare Revenue in AI In Vitro Diagnostic Business (2020-2025) & (US$ Million)
 Table 107. GE Healthcare Recent Development
 Table 108. Glooko Company Details
 Table 109. Glooko Business Overview
 Table 110. Glooko AI In Vitro Diagnostic Product
 Table 111. Glooko Revenue in AI In Vitro Diagnostic Business (2020-2025) & (US$ Million)
 Table 112. Glooko Recent Development
 Table 113. Adaptive Biotechnologies Company Details
 Table 114. Adaptive Biotechnologies Business Overview
 Table 115. Adaptive Biotechnologies AI In Vitro Diagnostic Product
 Table 116. Adaptive Biotechnologies Revenue in AI In Vitro Diagnostic Business (2020-2025) & (US$ Million)
 Table 117. Adaptive Biotechnologies Recent Development
 Table 118. Aidoc Company Details
 Table 119. Aidoc Business Overview
 Table 120. Aidoc AI In Vitro Diagnostic Product
 Table 121. Aidoc Revenue in AI In Vitro Diagnostic Business (2020-2025) & (US$ Million)
 Table 122. Aidoc Recent Development
 Table 123. Anumana Company Details
 Table 124. Anumana Business Overview
 Table 125. Anumana AI In Vitro Diagnostic Product
 Table 126. Anumana Revenue in AI In Vitro Diagnostic Business (2020-2025) & (US$ Million)
 Table 127. Anumana Recent Development
 Table 128. ARUP Laboratories Company Details
 Table 129. ARUP Laboratories Business Overview
 Table 130. ARUP Laboratories AI In Vitro Diagnostic Product
 Table 131. ARUP Laboratories Revenue in AI In Vitro Diagnostic Business (2020-2025) & (US$ Million)
 Table 132. ARUP Laboratories Recent Development
 Table 133. K Health Company Details
 Table 134. K Health Business Overview
 Table 135. K Health AI In Vitro Diagnostic Product
 Table 136. K Health Revenue in AI In Vitro Diagnostic Business (2020-2025) & (US$ Million)
 Table 137. K Health Recent Development
 Table 138. Lunit Company Details
 Table 139. Lunit Business Overview
 Table 140. Lunit AI In Vitro Diagnostic Product
 Table 141. Lunit Revenue in AI In Vitro Diagnostic Business (2020-2025) & (US$ Million)
 Table 142. Lunit Recent Development
 Table 143. Research Programs/Design for This Report
 Table 144. Key Data Information from Secondary Sources
 Table 145. Key Data Information from Primary Sources
 Table 146. Authors List of This Report


List of Figures
 Figure 1. AI In Vitro Diagnostic Picture
 Figure 2. Global AI In Vitro Diagnostic Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global AI In Vitro Diagnostic Market Share by Type: 2024 VS 2031
 Figure 4. Next-Generation Sequencing Technology Features
 Figure 5. PCR Technology Features
 Figure 6. Chemistry and IA Technology Features
 Figure 7. Pathology Technology Features
 Figure 8. Global AI In Vitro Diagnostic Market Size by Application (2020-2031) & (US$ Million)
 Figure 9. Global AI In Vitro Diagnostic Market Share by Application: 2024 VS 2031
 Figure 10. Cancer Diagnostics Case Studies
 Figure 11. Infectious Disease Testing Case Studies
 Figure 12. Metabolic Testing Case Studies
 Figure 13. Cardiac Testing Case Studies
 Figure 14. Diabetes Testing Case Studies
 Figure 15. AI In Vitro Diagnostic Report Years Considered
 Figure 16. Global AI In Vitro Diagnostic Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 17. Global AI In Vitro Diagnostic Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 18. Global AI In Vitro Diagnostic Market Share by Region: 2024 VS 2031
 Figure 19. Global AI In Vitro Diagnostic Market Share by Players in 2024
 Figure 20. Global Top AI In Vitro Diagnostic Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in AI In Vitro Diagnostic as of 2024)
 Figure 21. The Top 10 and 5 Players Market Share by AI In Vitro Diagnostic Revenue in 2024
 Figure 22. North America AI In Vitro Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 23. North America AI In Vitro Diagnostic Market Share by Country (2020-2031)
 Figure 24. United States AI In Vitro Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 25. Canada AI In Vitro Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 26. Europe AI In Vitro Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 27. Europe AI In Vitro Diagnostic Market Share by Country (2020-2031)
 Figure 28. Germany AI In Vitro Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 29. France AI In Vitro Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. U.K. AI In Vitro Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 31. Italy AI In Vitro Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 32. Russia AI In Vitro Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 33. Nordic Countries AI In Vitro Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 34. Asia-Pacific AI In Vitro Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 35. Asia-Pacific AI In Vitro Diagnostic Market Share by Region (2020-2031)
 Figure 36. China AI In Vitro Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 37. Japan AI In Vitro Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. South Korea AI In Vitro Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 39. Southeast Asia AI In Vitro Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 40. India AI In Vitro Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 41. Australia AI In Vitro Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 42. Latin America AI In Vitro Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 43. Latin America AI In Vitro Diagnostic Market Share by Country (2020-2031)
 Figure 44. Mexico AI In Vitro Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 45. Brazil AI In Vitro Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 46. Middle East & Africa AI In Vitro Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 47. Middle East & Africa AI In Vitro Diagnostic Market Share by Country (2020-2031)
 Figure 48. Turkey AI In Vitro Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 49. Saudi Arabia AI In Vitro Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 50. UAE AI In Vitro Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 51. Renalytix Revenue Growth Rate in AI In Vitro Diagnostic Business (2020-2025)
 Figure 52. Seegene Revenue Growth Rate in AI In Vitro Diagnostic Business (2020-2025)
 Figure 53. Sysmex Revenue Growth Rate in AI In Vitro Diagnostic Business (2020-2025)
 Figure 54. PathAI Revenue Growth Rate in AI In Vitro Diagnostic Business (2020-2025)
 Figure 55. Prognos Revenue Growth Rate in AI In Vitro Diagnostic Business (2020-2025)
 Figure 56. Qiagen Revenue Growth Rate in AI In Vitro Diagnostic Business (2020-2025)
 Figure 57. CloudMedX Health Revenue Growth Rate in AI In Vitro Diagnostic Business (2020-2025)
 Figure 58. Deepcell Revenue Growth Rate in AI In Vitro Diagnostic Business (2020-2025)
 Figure 59. Digital Diagnostics Revenue Growth Rate in AI In Vitro Diagnostic Business (2020-2025)
 Figure 60. EKF Diagnostics Holdings Revenue Growth Rate in AI In Vitro Diagnostic Business (2020-2025)
 Figure 61. Freenome Revenue Growth Rate in AI In Vitro Diagnostic Business (2020-2025)
 Figure 62. GE Healthcare Revenue Growth Rate in AI In Vitro Diagnostic Business (2020-2025)
 Figure 63. Glooko Revenue Growth Rate in AI In Vitro Diagnostic Business (2020-2025)
 Figure 64. Adaptive Biotechnologies Revenue Growth Rate in AI In Vitro Diagnostic Business (2020-2025)
 Figure 65. Aidoc Revenue Growth Rate in AI In Vitro Diagnostic Business (2020-2025)
 Figure 66. Anumana Revenue Growth Rate in AI In Vitro Diagnostic Business (2020-2025)
 Figure 67. ARUP Laboratories Revenue Growth Rate in AI In Vitro Diagnostic Business (2020-2025)
 Figure 68. K Health Revenue Growth Rate in AI In Vitro Diagnostic Business (2020-2025)
 Figure 69. Lunit Revenue Growth Rate in AI In Vitro Diagnostic Business (2020-2025)
 Figure 70. Bottom-up and Top-down Approaches for This Report
 Figure 71. Data Triangulation
 Figure 72. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Nano String

SIMILAR REPORTS

Artificial Intelligence in Diagnostics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global AI Diagnostics Market Research Report 2025
Infectious Disease In Vitro Diagnostics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Artificial Intelligence Diagnostics Market Research Report 2024
In Vitro Diagnosis IVD Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
AI in Medical Imaging Diagnosis Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global In Vitro Diagnostics Systems Market Insights Forecast to 2030
In Vitro Diagnostics IVD Kits Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
In Vitro Diagnostics Devices Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
AI In Diagnostic Imaging Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Artificial Intelligence AI in Medical Diagnostics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global In Vitro Screening Market Research Report 2025
Medical Devices for Diagnostics in Vitro Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Medical AI assisted Diagnosis Product Market Research Report 2024
Global AI Medical Diagnosis Tool Market Research Report 2024
Artificial Intelligence AI in Diagnostics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Artificial Intelligence in Healthcare Diagnosis Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
In Vitro Diagnostic Solution Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Medical AI assisted Diagnosis Market Research Report 2024
Global Breast AI assisted Diagnosis Market Research Report 2024

RELATED REPORTS

Global Taurine and Derivatives Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-26D19461
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global High Acuity Care Service Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-5D18285
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Surgical Waste Management Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-16G6108
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Healthcare Information Software Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-12H6156
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions